Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000552938 | SCV000645411 | benign | Dystonia 12 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001683573 | SCV001898118 | benign | not provided | 2019-05-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002260008 | SCV002539970 | benign | Alternating hemiplegia of childhood 2 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002260009 | SCV002539971 | benign | Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002260010 | SCV002539972 | benign | Developmental and epileptic encephalopathy 99 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000552938 | SCV002539974 | benign | Dystonia 12 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001683573 | SCV004143844 | benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | ATP1A3: BS1, BS2 |
Prevention |
RCV004553235 | SCV004743103 | benign | ATP1A3-related disorder | 2019-09-23 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Breakthrough Genomics, |
RCV001683573 | SCV005307504 | benign | not provided | criteria provided, single submitter | not provided |